MTOR and neoplasm: However, although this approach decreased tumour cell proliferation and, consequently, tumour volume in an NF1 mouse model,42,43 mTOR inhibitors were ineffective against pNF in one clinical trial44 but prolonged progression-free survival, albeit modestly, in another trial45 (NCT00634270).